College campuses are seeing an alarming uptick in abortions, according to the most recent data from the California Commission on the Status of Women and Girls.
There has been an increased effort by the state of California to push and expedite college students’ access to abortion drugs.
Across California’s public and private universities, 427 abortions were carried out in the last year, according to a report. Governor Gavin Newsom signed a bill into law in 2019, making these findings understandable.
The College Student Health Center Sexual and Reproductive Health Preparation Fund must be administered according to “readiness” guidelines outlined in Senate Bill 24 (SB24), which requires the Commission on the Status of Women and Girls to supervise the process. To finance specific initiatives about the provision of abortion by medication procedures, the fund distributes monies to the Commission for Public University Student Health Care Services clinics.
Some California schools are worried about the potential financial and legal ramifications of allowing more accessible access to abortion drugs for their pupils. Concerns about liability include but are not limited to
-the danger of an undetected ectopic pregnancy
-incomplete abortions
-severe bleeding and other possible complications.
Unions representing doctors in the United States and those representing California State University employees have reached an understanding on several memorandums. Medical professionals and others employed by SB24 are now legally protected by these memorandums from providing abortions via pharmaceutical procedures if they believe it would violate their moral, ethical, or religious beliefs.
Earlier this month, twenty attorneys general sent a letter. In contrast to surgical abortions, the letter emphasized the possible hazards of abortion tablets. The scientific community has reached an agreement that pharmaceutical abortions have a 5.96-fold higher risk of complications compared to aspiration abortions performed during the first trimester.
The use of progesterone to reverse the effects of the abortion pill, mifepristone, has lately come under fire from California Attorney General Rob Bonta.